Allianz Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-401,197
| Closed | -$27.3M | – | 1593 |
|
|
2022
Q3 | $27.3M | Buy |
+401,197
| New | +$27.3M | 0.06% | 343 |
|
|
2020
Q4 | – | Sell |
-14,509
| Closed | -$800K | – | 1948 |
|
|
2020
Q3 | $800K | Sell |
14,509
-6,395
| -31% | -$353K | ﹤0.01% | 1469 |
|
|
2020
Q2 | $1.32M | Sell |
20,904
-8,295
| -28% | -$523K | ﹤0.01% | 1367 |
|
|
2020
Q1 | $1.49M | Buy |
29,199
+2,810
| +11% | +$144K | ﹤0.01% | 1322 |
|
|
2019
Q4 | $2.1M | Buy |
26,389
+17,905
| +211% | +$1.42M | ﹤0.01% | 1446 |
|
|
2019
Q3 | $412K | Sell |
8,484
-20,516
| -71% | -$996K | ﹤0.01% | 1944 |
|
|
2019
Q2 | $1.53M | Buy |
29,000
+19,183
| +195% | +$1.01M | ﹤0.01% | 1630 |
|
|
2019
Q1 | $520K | Sell |
9,817
-28,312
| -74% | -$1.5M | ﹤0.01% | 1942 |
|
|
2018
Q4 | $1.55M | Sell |
38,129
-4,413
| -10% | -$180K | ﹤0.01% | 1539 |
|
|
2018
Q3 | $1.62M | Sell |
42,542
-4,641
| -10% | -$176K | ﹤0.01% | 1635 |
|
|
2018
Q2 | $2.13M | Buy |
47,183
+8,578
| +22% | +$388K | ﹤0.01% | 1503 |
|
|
2018
Q1 | $1.87M | Sell |
38,605
-9,730
| -20% | -$470K | ﹤0.01% | 1522 |
|
|
2017
Q4 | $1.9M | Buy |
+48,335
| New | +$1.9M | ﹤0.01% | 1550 |
|